ArticleFrontiers in medicine2025
Application value of oral targeted drug management program led by specialist nurses in continuous nursing for lung cancer patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Our research attempted to clarify impact of oral targeted drug management program led by specialist nurses on prognosis of non-small cell lung cancer (NSCLC) patients under treatment with oral targeted drugs out of hospital. Methods: NSCLC patients visiting our hospital enrollment as research cohort. The 80 patients received enrollment in our research and division into intervention group and control group through random number table method. The control group underwent conventional nursing. Based on control group, intervention group underwent an oral targeted drug management program led by specialist nurses. Patients received follow-up at 2, 4 and 6 months after discharge. Results: At follow-up of 4 and 6 months, incidence of missed medication events in intervention group displayed depletion relative to that in controls. At follow-up of 4 and 6 months, patients' medication compliance in intervention group displayed elevation relative to that in controls. Incidence of adverse drug reactions displayed depletion in intervention group. At follow-up of 2, 4 and 6 months, incidence of erythra in intervention group displayed depletion relative to that in controls. At follow-up of 6 months, general health, physical functioning and social functioning scores in intervention group displayed elevation relative to those in controls. The scores of above indicators in both groups at follow-up of 6 months displayed elevation relative to those at follow-up of 2 months. Conclusion: An oral targeted drug management program led by specialist nurses can effectively elevate patients' compliance, reduce incidence of adverse drug reactions and improve patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.